SpringWorks launches with $103M series A

On Sept. 25, SpringWorks Therapeutics LLC (New York, N.Y.) spun out of Pfizer Inc. (NYSE:PFE) with a tranched $103 million series A round led by Bain Capital Life Sciences, Bain Capital Double Impact and OrbiMed.

Pfizer and LifeArc also participated. Details regarding the round's tranches are not disclosed...